The understanding of cellular sources of kidney regeneration has rapidly evolved in the last
decade. It is now believed that regeneration occurs predominantly from cells that reside …

The kidney has a remarkable capacity to regenerate after injury, as it is not a terminally
differentiated organ. This regenerative potential is somehow incomplete, however, and as …

Hundreds of clinical trials are currently investigating the potential for mesenchymal stem
cells (MSC) to treat human disease, including kidney disease. There is tremendous …

Acute kidney injury (AKI) is a common clinical complication, associated with poor outcomes
and the development of chronic kidney disease. Despite major advances in the …

PURPOSE: The potential use of stem cells for acute and chronic renal injury is under
intensive investigation. We summarized the current literature on the potential therapeutic …

Cell-based therapy is an emerging field but one that has shown early promise for the
treatment of human kidney diseases. The most widely used cell is the mesenchymal stem …

Background: Acute kidney injury (AKI) is emerging as a public health problem in developing
and developed countries. It affects up to 7% of hospitalized patients, with a higher …

NATIVE KIDNEY ACUTE RENAL FAILURE (ARF) occurs in 2–5% of hospitalized patients
and is associated with high mortality (11). Allograft ARF occurs in 30–50% of deceased …

Kidney injury, stem cells and regeneration : Current Opinion in Nephrology and
Hypertension Kidney injury, stem cells and regeneration : Current Opinion in Nephrology …

The potential role of mesenchymal stem cells (MSCs, also called mesenchymal stromal
cells) in endogenous repair and cell-based therapies for acute kidney injury (AKI) is under …